Design, Synthesis and Biological Evaluation of Antibacterial Compounds
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 15 October 2024 | Viewed by 1218
Special Issue Editor
Interests: drug discovery; medicinal chemistry; antimicrobial resistance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) represents a significant challenge to future healthcare provision. The pipeline of antibiotics is essentially empty, and very few compounds are even in early-stage clinical trials. The development of novel antimicrobial agents for treating infections caused by multidrug-resistant (MDR) Gram-negative pathogens is an urgent priority. The high cost of drug development, coupled with a relatively short window of use to gain a return on investment, has resulted in a waning interest in antibiotic discovery among many pharmaceutical companies. The lack of new chemical scaffolds with antibiotic activity has further compounded the problem, leading to a discovery void. Therefore, it is important to innovate and disseminate information about antimicrobial chemical scaffolds to the wider scientific community. With this in mind, we have launched a Special Issue on the “Design, Synthesis and Biological Evaluation of Antimicrobial Compounds” with a submission deadline of June 2023. This Special Issue will focus on primary research articles describing the synthesis and microbiological evaluation of new chemical scaffolds with antimicrobial activities; however, we will also welcome review articles that provide critical analysis of antimicrobial drug discovery efforts and the current state of the field.
Prof. Dr. Khondaker Miraz Rahman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibacterial agents
- antifungal agents
- antibiotics
- antimicrobial resistance
- drug discovery
- medicinal chemistry
